Connection
Richard Schulick to Interleukin-2
This is a "connection" page, showing publications Richard Schulick has written about Interleukin-2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.404 |
|
|
|
-
Jain A, Slansky JE, Matey LC, Allen HE, Pardoll DM, Schulick RD. Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. Ann Surg Oncol. 2003 Aug; 10(7):810-20.
Score: 0.208
-
Schulick RD, Clerici M, Dolan MJ, Shearer GM. Limiting dilution analysis of interleukin-2-producing T cells responsive to recall and alloantigens in human immunodeficiency virus-infected and uninfected individuals. Eur J Immunol. 1993 Feb; 23(2):412-7.
Score: 0.101
-
Kato Y, Yoshimura K, Shin T, Verheul H, Hammers H, Sanni TB, Salumbides BC, Van Erp K, Schulick R, Pili R. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma. Clin Cancer Res. 2007 Aug 01; 13(15 Pt 1):4538-46.
Score: 0.069
-
Schulick RD, Weir MB, Miller MW, Cohen DJ, Bermas BL, Shearer GM. Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. Transplantation. 1993 Sep; 56(3):590-6.
Score: 0.026